Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Invest Ophthalmol Vis Sci

Retrieve available abstracts of 63 articles:
HTML format
Text format



Single Articles


    June 2017
  1. GALAN A, Barcelona PF, Nedev H, Sarunic MV, et al
    Subconjunctival Delivery of p75NTR Antagonists Reduces the Inflammatory, Vascular, and Neurodegenerative Pathologies of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:2852-2862.
    PubMed     Text format     Abstract available


  2. TIEN T, Zhang J, Muto T, Kim D, et al
    High Glucose Induces Mitochondrial Dysfunction in Retinal Muller Cells: Implications for Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:2915-2921.
    PubMed     Text format     Abstract available


  3. CAMMALLERI M, Locri F, Marsili S, Dal Monte M, et al
    The Urokinase Receptor-Derived Peptide UPARANT Recovers Dysfunctional Electroretinogram and Blood-Retinal Barrier Leakage in a Rat Model of Diabetes.
    Invest Ophthalmol Vis Sci. 2017;58:3138-3148.
    PubMed     Text format     Abstract available


    May 2017
  4. LIEW G, Benitez-Aguirre P, Craig ME, Jenkins AJ, et al
    Progressive Retinal Vasodilation in Patients With Type 1 Diabetes: A Longitudinal Study of Retinal Vascular Geometry.
    Invest Ophthalmol Vis Sci. 2017;58:2503-2509.
    PubMed     Text format     Abstract available


  5. LIM LS, Ling LH, Ong PG, Foulds W, et al
    Dynamic Responses in Retinal Vessel Caliber With Flicker Light Stimulation and Risk of Diabetic Retinopathy and Its Progression.
    Invest Ophthalmol Vis Sci. 2017;58:2449-2455.
    PubMed     Text format     Abstract available


  6. LUO T, Gast TJ, Vermeer TJ, Burns SA, et al
    Retinal Vascular Branching in Healthy and Diabetic Subjects.
    Invest Ophthalmol Vis Sci. 2017;58:2685-2694.
    PubMed     Text format     Abstract available


  7. VUJOSEVIC S, Simo R
    Local and Systemic Inflammatory Biomarkers of Diabetic Retinopathy: An Integrative Approach.
    Invest Ophthalmol Vis Sci. 2017;58:BIO68-BIO75.
    PubMed     Text format     Abstract available


  8. CHATZIRALLI I, Sergentanis TN, Crosby-Nwaobi R, Winkley K, et al
    Model for Risk-Based Screening of Diabetic Retinopathy in People With Newly-Diagnosed Type 2 Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2017;58:BIO99-BIO105.
    PubMed     Text format     Abstract available


    April 2017
  9. OBARA EA, Hannibal J, Heegaard S, Fahrenkrug J, et al
    Loss of Melanopsin-Expressing Retinal Ganglion Cells in Patients With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:2187-2192.
    PubMed     Text format     Abstract available


  10. ALDRICH BT, Schlotzer-Schrehardt U, Skeie JM, Burckart KA, et al
    Mitochondrial and Morphologic Alterations in Native Human Corneal Endothelial Cells Associated With Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2017;58:2130-2138.
    PubMed     Text format     Abstract available


  11. VANLANDINGHAM PA, Nuno DJ, Quiambao AB, Phelps E, et al
    Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:2095-2105.
    PubMed     Text format     Abstract available


  12. SUN MH, Shariati MA, Liao YJ
    Experimental Anterior Ischemic Optic Neuropathy in Diabetic Mice Exhibited Severe Retinal Swelling Associated With VEGF Elevation.
    Invest Ophthalmol Vis Sci. 2017;58:2296-2305.
    PubMed     Text format     Abstract available


    March 2017
  13. ZHUANG P, Muraleedharan CK, Xu S
    Intraocular Delivery of miR-146 Inhibits Diabetes-Induced Retinal Functional Defects in Diabetic Rat Model.
    Invest Ophthalmol Vis Sci. 2017;58:1646-1655.
    PubMed     Text format     Abstract available


  14. DIMITROVA G, Chihara E, Takahashi H, Amano H, et al
    Author Response: Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:1767.
    PubMed     Text format    


  15. TANG F, Cheung CY
    Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:1766.
    PubMed     Text format    


  16. GIOCANTI-AUREGAN A, Fajnkuchen F
    Author Response: Functional and Anatomic Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.
    Invest Ophthalmol Vis Sci. 2017;58:1857.
    PubMed     Text format    


  17. ASHRAF M
    Functional and Anatomic Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.
    Invest Ophthalmol Vis Sci. 2017;58:1856.
    PubMed     Text format    


    February 2017
  18. GIOCANTI-AUREGAN A, Hrarat L, Qu LM, Sarda V, et al
    Functional and Anatomical Outcomes in Patients With Serous Retinal Detachment in Diabetic Macular Edema Treated With Ranibizumab.
    Invest Ophthalmol Vis Sci. 2017;58:797-800.
    PubMed     Text format     Abstract available


  19. BREGMAN JA, Herren DJ, Estopinal CB, Chocron IM, et al
    Mitochondrial Haplogroups Affect Severity But Not Prevalence of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:1346-1351.
    PubMed     Text format     Abstract available


  20. LIU W, Wang S, Soetikno B, Yi J, et al
    Increased Retinal Oxygen Metabolism Precedes Microvascular Alterations in Type 1 Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2017;58:981-989.
    PubMed     Text format     Abstract available


    January 2017
  21. THOMAS AA, Feng B, Chakrabarti S
    ANRIL: A Regulator of VEGF in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:470-480.
    PubMed     Text format     Abstract available


  22. DIMITROVA G, Chihara E, Takahashi H, Amano H, et al
    Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2017;58:190-196.
    PubMed     Text format     Abstract available


  23. GHASEMI FALAVARJANI K, Iafe NA, Hubschman JP, Tsui I, et al
    Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
    Invest Ophthalmol Vis Sci. 2017;58:30-34.
    PubMed     Text format     Abstract available


    December 2016
  24. DAS A
    Diabetic Retinopathy: Battling the Global Epidemic.
    Invest Ophthalmol Vis Sci. 2016;57:6669-6682.
    PubMed     Text format    


  25. LAMMER J, Prager SG, Cheney MC, Ahmed A, et al
    Cone Photoreceptor Irregularity on Adaptive Optics Scanning Laser Ophthalmoscopy Correlates With Severity of Diabetic Retinopathy and Macular Edema.
    Invest Ophthalmol Vis Sci. 2016;57:6624-6632.
    PubMed     Text format     Abstract available


  26. CUNHA-VAZ J, Santos T, Ribeiro L, Alves D, et al
    OCT-Leakage: A New Method to Identify and Locate Abnormal Fluid Accumulation in Diabetic Retinal Edema.
    Invest Ophthalmol Vis Sci. 2016;57:6776-6783.
    PubMed     Text format     Abstract available


  27. PARK JH, Kang SS, Kim JY, Tchah H, et al
    Nerve Growth Factor Attenuates Apoptosis and Inflammation in the Diabetic Cornea.
    Invest Ophthalmol Vis Sci. 2016;57:6767-6775.
    PubMed     Text format     Abstract available


  28. PRASAD T, Roksnoer LC, Zhu P, Verma A, et al
    Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.
    Invest Ophthalmol Vis Sci. 2016;57:6722-6730.
    PubMed     Text format     Abstract available


    November 2016
  29. BLAIR NP, Wanek J, Felder AE, Brewer KC, et al
    Inner Retinal Oxygen Delivery, Metabolism, and Extraction Fraction in Ins2Akita Diabetic Mice.
    Invest Ophthalmol Vis Sci. 2016;57:5903-5909.
    PubMed     Text format     Abstract available


  30. ISHIBAZAWA A, Nagaoka T, Yokota H, Takahashi A, et al
    Characteristics of Retinal Neovascularization in Proliferative Diabetic Retinopathy Imaged by Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2016;57:6247-6255.
    PubMed     Text format     Abstract available


  31. FICKWEILER W, Klaassen I, Vogels IM, Hooymans JM, et al
    Association of Circulating Markers With Outcome Parameters in the Bevacizumab and Ranibizumab in Diabetic Macular Edema Trial.
    Invest Ophthalmol Vis Sci. 2016;57:6234-6241.
    PubMed     Text format     Abstract available


  32. TAVARES FERREIRA J, Alves M, Dias-Santos A, Costa L, et al
    Retinal Neurodegeneration in Diabetic Patients Without Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:6455-6460.
    PubMed     Text format     Abstract available


    October 2016
  33. ABRAMOFF MD, Lou Y, Erginay A, Clarida W, et al
    Improved Automated Detection of Diabetic Retinopathy on a Publicly Available Dataset Through Integration of Deep Learning.
    Invest Ophthalmol Vis Sci. 2016;57:5200-5206.
    PubMed     Text format     Abstract available


  34. ZHANG M, Hwang TS, Dongye C, Wilson DJ, et al
    Automated Quantification of Nonperfusion in Three Retinal Plexuses Using Projection-Resolved Optical Coherence Tomography Angiography in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:5101-5106.
    PubMed     Text format     Abstract available


  35. NAIR P, Aiello LP, Gardner TW, Jampol LM, et al
    Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop.
    Invest Ophthalmol Vis Sci. 2016;57:5127-5142.
    PubMed     Text format    


  36. EL-FAYOUMI D, Badr Eldine NM, Esmael AF, Ghalwash D, et al
    Retinal Nerve Fiber Layer and Ganglion Cell Complex Thicknesses Are Reduced in Children With Type 1 Diabetes With No Evidence of Vascular Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:5355-5360.
    PubMed     Text format     Abstract available


  37. GUDURU A, Martz TG, Waters A, Kshirsagar AV, et al
    Oxygen Saturation of Retinal Vessels in All Stages of Diabetic Retinopathy and Correlation to Ultra-Wide Field Fluorescein Angiography.
    Invest Ophthalmol Vis Sci. 2016;57:5278-5284.
    PubMed     Text format     Abstract available


  38. ARONEY C, Fraser-Bell S, Lamoureux EL, Gillies MC, et al
    Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2016;57:5541-5546.
    PubMed     Text format     Abstract available


  39. CHEUNG CY, Hui EY, Lee CH, Kwok KH, et al
    Impact of Genetic Loci Identified in Genome-Wide Association Studies on Diabetic Retinopathy in Chinese Patients With Type 2 Diabetes.
    Invest Ophthalmol Vis Sci. 2016;57:5518-5524.
    PubMed     Text format     Abstract available


  40. FELDER AE, Wanek J, Blair NP, Joslin CE, et al
    The Effects of Diabetic Retinopathy Stage and Light Flicker on Inner Retinal Oxygen Extraction Fraction.
    Invest Ophthalmol Vis Sci. 2016;57:5586-5592.
    PubMed     Text format     Abstract available


  41. BEK T, Jorgensen CM
    The Systemic Blood Pressure and Oxygen Saturation in Retinal Arterioles Predict the Effect of Intravitreal Anti-VEGF Treatment on Diabetic Maculopathy.
    Invest Ophthalmol Vis Sci. 2016;57:5429-5434.
    PubMed     Text format     Abstract available


  42. MISHRA M, Kowluru RA
    The Role of DNA Methylation in the Metabolic Memory Phenomenon Associated With the Continued Progression of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:5748-5757.
    PubMed     Text format     Abstract available


    September 2016
  43. MAN RE, Fenwick EK, Sabanayagam C, Li LJ, et al
    Differential Impact of Unilateral and Bilateral Classifications of Diabetic Retinopathy and Diabetic Macular Edema on Vision-Related Quality of Life.
    Invest Ophthalmol Vis Sci. 2016;57:4655-60.
    PubMed     Text format     Abstract available


  44. MCDOWELL RE, McGahon MK, Augustine J, Chen M, et al
    Diabetes Impairs the Aldehyde Detoxifying Capacity of the Retina.
    Invest Ophthalmol Vis Sci. 2016;57:4762-71.
    PubMed     Text format     Abstract available


  45. ZAHID S, Dolz-Marco R, Freund KB, Balaratnasingam C, et al
    Fractal Dimensional Analysis of Optical Coherence Tomography Angiography in Eyes With Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:4940-4947.
    PubMed     Text format     Abstract available


  46. TAMAKI K, Usui-Ouchi A, Murakami A, Ebihara N, et al
    Fibrocytes and Fibrovascular Membrane Formation in Proliferative Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:4999-5005.
    PubMed     Text format     Abstract available


    August 2016
  47. JEON SJ, Kwon JW, La TY, Park CK, et al
    Characteristics of Retinal Nerve Fiber Layer Defect in Nonglaucomatous Eyes With Type II Diabetes.
    Invest Ophthalmol Vis Sci. 2016;57:4008-4015.
    PubMed     Text format     Abstract available


  48. MISHRA M, Lillvis J, Seyoum B, Kowluru RA, et al
    Peripheral Blood Mitochondrial DNA Damage as a Potential Noninvasive Biomarker of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:4035-44.
    PubMed     Text format     Abstract available


  49. LIU H, Tang J, Du Y, Saadane A, et al
    Photoreceptor Cells Influence Retinal Vascular Degeneration in Mouse Models of Retinal Degeneration and Diabetes.
    Invest Ophthalmol Vis Sci. 2016;57:4272-81.
    PubMed     Text format     Abstract available


  50. TONADE D, Liu H, Kern TS
    Photoreceptor Cells Produce Inflammatory Mediators That Contribute to Endothelial Cell Death in Diabetes.
    Invest Ophthalmol Vis Sci. 2016;57:4264-71.
    PubMed     Text format     Abstract available


  51. LOPES DE FARIA JM, Duarte DA, Montemurro C, Papadimitriou A, et al
    Defective Autophagy in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:4356-66.
    PubMed     Text format     Abstract available


    July 2016
  52. KIM AY, Chu Z, Shahidzadeh A, Wang RK, et al
    Quantifying Microvascular Density and Morphology in Diabetic Retinopathy Using Spectral-Domain Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2016;57:OCT362-70.
    PubMed     Text format     Abstract available


  53. HASEGAWA N, Nozaki M, Takase N, Yoshida M, et al
    New Insights Into Microaneurysms in the Deep Capillary Plexus Detected by Optical Coherence Tomography Angiography in Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2016;57:OCT348-55.
    PubMed     Text format     Abstract available


  54. WANEK J, Blair NP, Chau FY, Lim JI, et al
    Alterations in Retinal Layer Thickness and Reflectance at Different Stages of Diabetic Retinopathy by En Face Optical Coherence Tomography.
    Invest Ophthalmol Vis Sci. 2016;57:OCT341-7.
    PubMed     Text format     Abstract available


  55. BHANUSHALI D, Anegondi N, Gadde SG, Srinivasan P, et al
    Linking Retinal Microvasculature Features With Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.
    Invest Ophthalmol Vis Sci. 2016;57:OCT519-OCT525.
    PubMed     Text format     Abstract available


  56. AL-SHEIKH M, Akil H, Pfau M, Sadda SR, et al
    Swept-Source OCT Angiography Imaging of the Foveal Avascular Zone and Macular Capillary Network Density in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:3907-3913.
    PubMed     Text format     Abstract available


    June 2016
  57. JEONG SY, Park SJ, Chin HS, Kim SH, et al
    Spectral-Domain Optical Coherence Tomography Features in Open-Angle Glaucoma With Diabetes Mellitus and Inadequate Glycemic Control.
    Invest Ophthalmol Vis Sci. 2016;57:3024-31.
    PubMed     Text format     Abstract available


  58. KWON SH, Shin JP, Kim IT, Park DH, et al
    Association of Plasma Semaphorin 3A With Phenotypes of Diabetic Retinopathy and Nephropathy.
    Invest Ophthalmol Vis Sci. 2016;57:2983-9.
    PubMed     Text format     Abstract available


  59. ZHAO M, Hu Y, Yu Y, Lin Q, et al
    Involvement of IL-37 in the Pathogenesis of Proliferative Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:2955-62.
    PubMed     Text format     Abstract available


  60. AMATO R, Biagioni M, Cammalleri M, Dal Monte M, et al
    VEGF as a Survival Factor in Ex Vivo Models of Early Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:3066-76.
    PubMed     Text format     Abstract available


  61. TARCHICK MJ, Bassiri P, Rohwer RM, Samuels IS, et al
    Early Functional and Morphologic Abnormalities in the Diabetic Nyxnob Mouse Retina.
    Invest Ophthalmol Vis Sci. 2016;57:3496-508.
    PubMed     Text format     Abstract available


    May 2016
  62. WANG J, Cui X, Roon P, Smith SB, et al
    Role of Sigma 1 Receptor in Retinal Degeneration of the Ins2Akita/+ Murine Model of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2016;57:2770-2781.
    PubMed     Text format     Abstract available


    April 2016
  63. SCHWEITZER C, Korobelnik JF, Boniol M, Cougnard-Gregoire A, et al
    Associations of Biomechanical Properties of the Cornea With Environmental and Metabolic Factors in an Elderly Population: The ALIENOR Study.
    Invest Ophthalmol Vis Sci. 2016;57:2003-2011.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: